The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
Revenue from operations surged 30% year-on-year to Rs. 68,645 million
The company’s EBITDA margin remained resilient above 20%
The therapy is currently completing Phase 1 clinical trials in renal cell carcinoma and non-small cell lung cancer
Capital expenditure stood at Rs. 405 crore to date against a planned Rs. 700 crore for FY26
Pfizer’s anti-infectives portfolio includes both established therapies for moderate to severe infections and newer, clinically robust antimicrobial treatments
LIVMARLI’s new tablet form offers patients weighing 22 kg or more a convenient, one-tablet-per-dose option, complementing the existing 9.5 mg/ml oral solution
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Stalevo Tablets
This Orphan Drug Designation from the USFDA underlines the urgent medical need to develop a therapy for sickle cell disease
The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space across a 12-acre site
Subscribe To Our Newsletter & Stay Updated
